Outcomes of Robotic MIDCAB With Hybrid PCI for Multivessel Coronary Disease Involving the Left Main: Results of 62 Cases
Hybrid robotic MIDCAB for patients with and without LM disease can be performed with acceptable results in selected patients. However, it is not possible to draw definitive conclusions regarding safety and efficacy compared with conventional coronary artery bypass grafting.
Authors
- Didier F. Loulmet
- Noritsugu Naito (ORCID: https://orcid.org/0000-0002-1789-5993)
- Eugene A. Grossi (ORCID: https://orcid.org/0000-0002-2066-7035)
- Homam Ibrahim (ORCID: https://orcid.org/0000-0002-6728-3143)
- Louai Razzouk (ORCID: https://orcid.org/0000-0002-0306-6182)
- Michael Dorsey (ORCID: https://orcid.org/0000-0002-1117-6410)
- Cezar Staniloae (ORCID: https://orcid.org/0000-0001-8970-8889)
Institutions
- NYU Langone Health (US)
Publication Details
- Journal
- Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1177/15569845251324200
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00